PURPOSE: Colloids are administered to more patients than crystalloids, although recent evidence suggests that colloids may possibly be harmful in some patients. The European Society of Intensive Care Medicine therefore assembled a task force to compile consensus recommendations based on the current best evidence for the safety and efficacy of the currently most frequently used colloids--hydroxyethyl starches (HES), gelatins and human albumin. METHODS: Meta-analyses, systematic reviews and clinical studies of colloid use were evaluated for the treatment of volume depletion in mixed intensive care unit (ICU), cardiac surgery, head injury, sepsis and organ donor patients. Clinical endpoints included mortality, kidney function and bleeding. The relevance of concentration and dosage was also assessed. Publications from 1960 until May 2011 were included. The quality of available evidence and strength of recommendations were based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. RECOMMENDATIONS AND CONCLUSIONS: We recommend not to use HES with molecular weight ≥ 200 kDa and/or degree of substitution >0.4 in patients with severe sepsis or risk of acute kidney injury and suggest not to use 6% HES 130/0.4 or gelatin in these populations. We recommend not to use colloids in patients with head injury and not to administer gelatins and HES in organ donors. We suggest not to use hyperoncotic solutions for fluid resuscitation. We conclude and recommend that any new colloid should be introduced into clinical practice only after its patient-important safety parameters are established.
PURPOSE: Colloids are administered to more patients than crystalloids, although recent evidence suggests that colloids may possibly be harmful in some patients. The European Society of Intensive Care Medicine therefore assembled a task force to compile consensus recommendations based on the current best evidence for the safety and efficacy of the currently most frequently used colloids--hydroxyethyl starches (HES), gelatins and human albumin. METHODS: Meta-analyses, systematic reviews and clinical studies of colloid use were evaluated for the treatment of volume depletion in mixed intensive care unit (ICU), cardiac surgery, head injury, sepsis and organ donorpatients. Clinical endpoints included mortality, kidney function and bleeding. The relevance of concentration and dosage was also assessed. Publications from 1960 until May 2011 were included. The quality of available evidence and strength of recommendations were based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. RECOMMENDATIONS AND CONCLUSIONS: We recommend not to use HES with molecular weight ≥ 200 kDa and/or degree of substitution >0.4 in patients with severe sepsis or risk of acute kidney injury and suggest not to use 6% HES 130/0.4 or gelatin in these populations. We recommend not to use colloids in patients with head injury and not to administer gelatins and HES in organ donors. We suggest not to use hyperoncotic solutions for fluid resuscitation. We conclude and recommend that any new colloid should be introduced into clinical practice only after its patient-important safety parameters are established.
Authors: Simon Finfer; Suzanne McEvoy; Rinaldo Bellomo; Colin McArthur; John Myburgh; Robyn Norton Journal: Intensive Care Med Date: 2010-10-06 Impact factor: 17.440
Authors: Ramiro Arellano; Bing Siang Gan; Mary Jane Salpeter; Erik Yeo; Stuart McCluskey; Ruxandra Pinto; Jonathan Irish; Douglas C Ross; D John Doyle; John Parkin; Dale Brown; Lorne Rotstein; Ian Witterick; Wayne Matthews; John Yoo; Peter C Neligan; Pat Gullane; Howard Lampe Journal: Anesth Analg Date: 2005-06 Impact factor: 5.108
Authors: Laurent Brochard; Fekri Abroug; Matthew Brenner; Alain F Broccard; Robert L Danner; Miquel Ferrer; Franco Laghi; Sheldon Magder; Laurent Papazian; Paolo Pelosi; Kees H Polderman Journal: Am J Respir Crit Care Med Date: 2010-05-15 Impact factor: 21.405
Authors: Simon Finfer; Bette Liu; Colman Taylor; Rinaldo Bellomo; Laurent Billot; Deborah Cook; Bin Du; Colin McArthur; John Myburgh Journal: Crit Care Date: 2010-10-15 Impact factor: 9.097
Authors: Matthias Jacob; Daniel Chappell; Peter Conzen; Mahlon M Wilkes; Bernhard F Becker; Markus Rehm Journal: Crit Care Date: 2008-03-04 Impact factor: 9.097
Authors: Jan Claassen; Fabio S Taccone; Peter Horn; Martin Holtkamp; Nino Stocchetti; Mauro Oddo Journal: Intensive Care Med Date: 2013-05-08 Impact factor: 17.440